Assignee
WUHAN HEALTHGEN BIOTECHNOLOGY CORP
CN·5 granted patents·2 pending applications·5 citations·filing 2013–2024
Top patents by PatentIndex Score
7 records- 0191US11913002B2Modified plant endosperm specific promoter and use thereofWUHAN HEALTHGEN BIOTECHNOLOGY CORP·Filed 2021·Granted Feb 27, 2024·2 cites·20 claims
- 0275US12188030B2Modified plant endosperm specific promoter and use thereofWUHAN HEALTHGEN BIOTECHNOLOGY CORP·Filed 2024·Granted Jan 7, 2025·0 cites·9 claims
- 0371US10730926B2Chromatographic method for isolating and purifying high-purity recombined human serum albuminWUHAN HEALTHGEN BIOTECHNOLOGY CORP·Filed 2013·Granted Aug 4, 2020·3 cites·20 claims
- 0466US2025059257A1Preparation method and application of high-purity plant-derived recombinant human serum albuminWUHAN HEALTHGEN BIOTECHNOLOGY CORP·Filed 2024·Application pending·0 cites
- 0564US12215139B2Preparation method and application of high-purity plant-derived recombinant human serum albuminWUHAN HEALTHGEN BIOTECHNOLOGY CORP·Filed 2023·Granted Feb 4, 2025·0 cites·14 claims
- 0657US2024197894A1Recombinant human serum albumin-therapeutic drug conjugateWUHAN HEALTHGEN BIOTECHNOLOGY CORP·Filed 2023·Application pending·0 cites
- 0743US12195497B2Method for separating and purifying recombinant human fibronectin from genetically engineered rice seedWUHAN HEALTHGEN BIOTECHNOLOGY CORP·Filed 2019·Granted Jan 14, 2025·0 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when WUHAN HEALTHGEN BIOTECHNOLOGY CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →